|
Volumn 31, Issue 2, 2010, Pages 56-69
|
Attention-deficit/hyperactivity disorder
a b c |
Author keywords
[No Author keywords available]
|
Indexed keywords
AMFEBUTAMONE;
AMPHETAMINE;
ATOMOXETINE;
CENTRAL STIMULANT AGENT;
CLONIDINE;
DEXAMPHETAMINE;
DEXMETHYLPHENIDATE;
GUANFACINE;
LISDEXAMFETAMINE;
METHAMPHETAMINE;
METHYLPHENIDATE;
TRICYCLIC ANTIDEPRESSANT AGENT;
ABDOMINAL PAIN;
ACADEMIC ACHIEVEMENT;
ATTENTION DEFICIT DISORDER;
BEHAVIOR THERAPY;
DECREASED APPETITE;
DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS;
DIARRHEA;
DIFFERENTIAL DIAGNOSIS;
DRUG CONTRAINDICATION;
DRUG DOSE INCREASE;
DRUG DOSE TITRATION;
DRUG HALF LIFE;
DYSPEPSIA;
EMOTION;
EVALUATION;
FATIGUE;
HALLUCINATION;
HEADACHE;
HEPATITIS;
HUMAN;
HYPERACTIVITY;
IMPULSIVENESS;
IRRITABILITY;
LOW DRUG DOSE;
MANIA;
MOOD DISORDER;
NAUSEA;
PHYSICIAN;
PREVALENCE;
PROGNOSIS;
PSYCHOSOCIAL WITHDRAWAL;
REINFORCEMENT;
REVIEW;
SIDE EFFECT;
SLEEP DISORDER;
SOCIAL ASPECT;
SOMNOLENCE;
SYMPTOM;
TIC;
VOMITING;
WEIGHT REDUCTION;
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;
BRAIN;
CHILD;
DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS;
FEMALE;
HUMANS;
MAGNETIC RESONANCE IMAGING;
MALE;
PREVALENCE;
RISK FACTORS;
|
EID: 76749167970
PISSN: 01919601
EISSN: 15263347
Source Type: Journal
DOI: 10.1542/pir.31-2-56 Document Type: Review |
Times cited : (37)
|
References (0)
|